European markets are heading for a higher open, with investor focus on the German government as it votes on historic debt ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred worries about the U.S. economy.

European markets closed lower as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump’s ...

More than 120 entries have been whittled down to the top 25 women aged under 40 tipped to spearhead the next generation of leading partners.

Class actions are gaining momentum in the food and beverage sector, according to Law.com Radar. The platform surfaced 24 ...

Fictionalized action films based on the retellings of the Persian Wars, a series of conflicts between the Empire of Persia and Greek city-states.

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

In brief: Elon Musk's close relationship with Donald Trump and his outspoken views have led to a backlash against Tesla vehicles in many countries around the world. However, sales of the EVs in ...

Perhaps the most surprising company on the rise is Takeda. The Japanese company ... and Brintellix (major depressive disorder). Meanwhile Novo Nordisk has also seen its ranking surge up 15 places ...

Stock futures are little changed Wednesday night after the major averages rebounded on hopes for concessions on President Donald Trump's tariffs. Futures tied to the Dow Jones Industrial Average ...